Women and Infants Hospital of Rhode Island
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Women and Infants Hospital of Rhode Island sits in the top decile of US sponsors by registered trial count (#318 of 15,742 sponsors by registered trial count).
Women and Infants Hospital of Rhode Island: 65 sponsored US clinical trials, 14 recruiting.
Women and Infants Hospital of Rhode Island sponsors 65 registered US clinical trials on ClinicalTrials.gov, 14 of them currently recruiting, and 39 completed. 9 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postpartum Depression, with 3 trials.
Top-decile sponsor footprint
Women and Infants Hospital of Rhode Island ranks in the top decile of sponsors by registered trial count (#318 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
39 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
65 total, page 2 of 2
A New Prenatal Blood Test for Down Syndrome
NCT00877292
Effect of Cervical Occlusion During Intrauterine Insemination (IUI)
NCT00951171
Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants
NCT01860573
Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.
NCT00711529
Maternal Hypothyroidism in Pregnancy
NCT00818896
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
NCT00602355
Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator
NCT01440647
Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
NCT00436150
Treatment for Acute Postoperative Voiding Dysfunction
NCT01189136
Doxil and Gemcitabine in Recurrent Ovarian Cancer
NCT00312650
Depression Prevention for Pregnant Women on Public Assistance
NCT00601757
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.
NCT00287482
Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
NCT00106262
Graft-Augmented Rectocele Repair-A Randomized Surgical Trial
NCT00321867
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
NCT00315159
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 5 |
| Phase 4 | 4 |
What is open in the Women and Infants Hospital of Rhode Island pipeline
14 recruiting of 65 indexed (22% open); 39 completed (60%).
Phase mix: 9 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Postpartum Depression (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Women and Infants Hospital of Rhode Island: open-pipeline peers nationwide
Peers matched on 65 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Women and Infants Hospital of Rhode Island sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 65 trials (± recruiting share)
- BeiGene · 65 trials · 14% recruiting
- Glaxo Wellcome · 65 trials · 0% recruiting
- LEO Pharma · 65 trials · 5% recruiting
- Neurocrine Biosciences · 65 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Merck Sharp & Dohme · 22% recruiting · 558 trials
- UNC Lineberger Comprehensive Cancer Center · 22% recruiting · 366 trials
- AbbVie · 21% recruiting · 526 trials
- Florida State University · 21% recruiting · 219 trials
Related
What to do with this Women and Infants Hospital of Rhode Island page
65 registered trials is a research-attention snapshot, not an endorsement of Women and Infants Hospital of Rhode Island or any single study.
- 14 of Women and Infants Hospital of Rhode Island's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Postpartum Depression is the condition Women and Infants Hospital of Rhode Island studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postpartum Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Women and Infants Hospital of Rhode Island pipeline card: 65 registered trials from official public datasets.Report a data error.